Navigation Links
China’s AIDS vaccine-successfully finishes first phas

According to the government health officials, initial clinical trials show that China’s first AIDS vaccine is safe and probably effective//.

"Forty-nine healthy people who received the injections showed no severe adverse reactions after 180 days, proving the vaccine was safe," said Zhang Wei, head of the pharmaceutical registration department of the State Food and Drug Administration (SFDA).

"The recipients appeared immune to the HIV-1 virus 15 days after the injection, indicating the vaccine worked well in stimulating the body's immunity," he told a press conference in Beijing.

The first phase of clinical trials, which focused on the vaccine’s safety comes to an end with these results.

Sang Guowei, director of the National Institute for the Control of Pharmaceutical and Biological Products, said that the second-round tests will require at least 300 volunteers and the third phase at least 500.

According to Chen Jie, deputy director of the Guangxi Regional Center for Disease Control and Prevention, participation of high-risk groups will be involved in the later trials.

The first phase of clinical trials began in March 2005 in Nanning, which is the capital of the Guangxi Zhuang Autonomous Region. 33 men and 16 women aged between 18 and 50 years, volunteered for this trial. They were divided into 8 groups, of which, 6 groups were given a single AIDS vaccine and the others were injected with a combined AIDS vaccine. This was reported by the Guangxi center for disease control.

”The HIV-1 specific cells injected into the recipients were the DNA fragments of the virus that don't cause infection,” Sang said.

”Some recipients' cells and body fluids in the combined group appeared immune to the HIV-1 virus.”

Kong Wei, leader of the research team and a professor at Jilin University said, ”A total 344 blood samples were taken from the volunteers, with each one donating five to 10 samples.”

The volunteers exhibited no serious ill effects even after 180 days of observation.

According to the SFDA officials, the scientists will continue analysis of the results of the first phase, before SFDA approves the beginning of the second phase, after a rigorous assessment.

Assessment of safety and immunity comprises the second phase while the third is concerned with how the vaccine will provide protection to the high-risk groups.

According to the 2005 Update on the HIV/AIDS Epidemic and Response in China, 6,50,000 people in this country are living with HIV/AIDS while 75,000 with clinical AIDS.

Scientists and other experts concerned with the drastic increase in the spread of the disease, urged the State Council, China's cabinet, to raise funding for and encourage innovation and cooperation in research.

International funding worth 123.2 million U.S. dollars was given to China recently by the Global Fund to Fight HIV/AIDS, Tuberculosis and Malria.
'"/>




Related medicine news :

1. Mystery over bird flu infection to Ms. Zhou – China’s 7th bird flu victm
2. Lower Birth Rate and Fewer Girls under China’s one Child Polic
3. Infant receives first bloodless liver transplant
4. Oracle Corp. to help build worlds first "Digital Hospital"
5. FDA approves first pocket-sized EKG machine
6. Valerian was first epilepsy drug
7. New device for ailing heart fitted into first patient
8. Canada helps in giving birth to world first baby from frozen egg
9. SNUPPY – Woo Suk Hwang reveals World’s first dog cloe
10. Successful creation of human embryos from a single parent for the first time
11. A first for India - IVF baby born of surrogacy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/16/2017)... ... January 16, 2017 , ... With the Grand Opening ... January 8 for use by sports teams and the general public. Built in five ... that can also be converted into basketball or pickleball courts. The space is also ...
(Date:1/16/2017)... TX (PRWEB) , ... January 16, 2017 , ... ... dental office , Antoine Dental Center, is currently offering complimentary consultations and financing ... have their teeth examined for bite irregularities and learn about their orthodontic options. ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... ... manufacturer Prairie Seating. Prairie’s award-winning Reflection® brand of custom seating systems has a ... acquisition provides Permobil with a platform for innovation and growth in the custom ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... ... announce their recent partnership with an innovator in the wheelchair accessibility industry, ... motivate their dealer salespeople to sell wheelchair accessible vehicles. With this new incentive ...
(Date:1/16/2017)... ... January 16, 2017 , ... Date aired: January ... , Sharon Kleyne, America’s leading water educator, researcher and advocate welcomed health ... program, The Sharon Kleyne Hour Power of Water, Global Climate Change and Your ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... , Jan. 16, 2017  This report by ... central catheters market for the period 2016–2024. The ... updates and information related to market opportunities in ... comprehensive market study demonstrates the various dynamics that ... future status of the global peripherally inserted central ...
(Date:1/16/2017)... , Jan. 16, 2017 Derek ... Potts Law Firm, was recently appointed Liaison Counsel in ... (JCCP) for all Xarelto cases. In this role, Potts ... parties and will actively assist the Court and Co ... with Milstein Adelman Jackson Fairchild & ...
(Date:1/16/2017)... 2017  According to Kalorama Information, the global ... at $4.9 billion for 2016.  The growing number ... aging population with significant diagnostic needs, along with ... the market for the modality.  The healthcare market ... focuses on the worldwide market, providing market size ...
Breaking Medicine Technology: